CT coronary plaque burden in asymptomatic patients with familial hypercholesterolaemia

Heart

Volumn 97, Issue 14, 2011, Pages 1151-1157

  Neefjes, Lisan A ^a,b   Ten Kate, Gert Jan R ^a,b   Rossi, Alexia ^a   Galema Boers, Annette J ^a   Langendonk, Janneke G ^a   Weustink, Annick C ^a   Moelker, Adriaan ^a   Nieman, Koen ^a   Mollet, Nico R ^a   Krestin, Gabriel P ^a   Sijbrands, Eric J ^a   De Feyter, Pim J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CIPROFIBRATE; COLESTYRAMINE; EZETIMIBE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IOPROMIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ADULT; AGE; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY CALCIUM SCORE; DISEASE SEVERITY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SEX DIFFERENCE; THORAX PAIN; UNSPECIFIED SIDE EFFECT;

ASYMPTOMATIC DISEASES; CALCINOSIS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIA TYPE II; LINEAR MODELS; MALE; MIDDLE AGED; NETHERLANDS; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79959344590     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2010.220699     Document Type: Article

References (36)

1. Anon. Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group. BMJ 1991;303:893-6.
2. Austin MA, Hutter CM, Zimmern RL, et al. Familial hypercholesterolemia and coronary heart disease: a HuGE association review. Am J Epidemiol 2004;160:421-9. (Pubitemid 39166974)
3. de Sauvage Nolting PR, Defesche JC, Buirma RJ, et al. Prevalence and significance of cardiovascular risk factors in a large cohort of patients with familial hypercholesterolaemia. J Intern Med 2003;253:161-8. (Pubitemid 36197536)
4. Mabuchi H, Koizumi J, Shimizu M, et al. Development of coronary heart disease in familial hypercholesterolemia. Circulation 1989;79:225-32.
5. Versmissen J, Oosterveer DM, Yazdanpanah M, et al. Efficacy of statins in familial hypercholesterolaemia: a long term cohort study. BMJ 2008;337:a2423.
6. Miname MH, Ribeiro MS 2nd, Parga Filho J, et al. Evaluation of subclinical atherosclerosis by computed tomography coronary angiography and its association with risk factors in familial hypercholesterolemia. Atherosclerosis 2010;213:486-91.
7. van Aalst-Cohen ES, Jansen AC, Tanck MW, et al. Diagnosing familial hypercholesterolaemia: the relevance of genetic testing. Eur Heart J 2006;27:2240-6. (Pubitemid 44412840)
8. Diamond GA. A clinically relevant classification of chest discomfort. J Am Coll Cardiol 1983;1:574-5. (Pubitemid 13063216)
9. Weustink AC, Mollet NR, Neefjes LA, et al. Preserved diagnostic performance of dual-source CT coronary angiography with reduced radiation exposure and cancer risk. Radiology 2009;252:53-60.
10. Weustink AC, Mollet NR, Pugliese F, et al. Optimal electrocardiographic pulsing windows and heart rate: effect on image quality and radiation exposure at dualsource coronary CT angiography. Radiology 2008;248:792-8.
11. Shrimpton P. Assessment of patient dose in CT: appendix CdEuropean guidelines for multislice computed tomography. European Commission project MSCT: CT safety & efficacy - a broad perspective, 2004. http://www.msct.eu/PDF- FILES/Appendix%20paediatric%20CT%20Dosimetry.pdf (accessed 20 Nov 2008).
12. Agatston AS, Janowitz WR, Hildner FJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827-32. (Pubitemid 20101575)
13. Austen WG, Edwards JE, Frye RL, et al. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975;51:5-40.
14. Hoff JA, Chomka EV, Krainik AJ, et al. Age and gender distributions of coronary artery calcium detected by electron beam tomography in 35,246 adults. Am J Cardiol 2001;87:1335-9. (Pubitemid 32523014)
15. McClelland RL, Chung H, Detrano R, et al. Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2006;113:30-7. (Pubitemid 43958485)
16. Mitchell TL, Pippin JJ, Devers SM, et al. Age- and sex-based nomograms from coronary artery calcium scores as determined by electron beam computed tomography. Am J Cardiol 2001;87:453-6, A6.
17. Nasir K, Raggi P, Rumberger JA, et al. Coronary artery calcium volume scores on electron beam tomography in 12,936 asymptomatic adults. Am J Cardiol 2004;93:1146-9. (Pubitemid 38521045)
18. Choi EK, Choi SI, Rivera JJ, et al. Coronary computed tomography angiography as a screening tool for the detection of occult coronary artery disease in asymptomatic individuals. J Am Coll Cardiol 2008;52:357-65. (Pubitemid 352001351)
19. Kelly JL, Thickman D, Abramson SD, et al. Coronary CT angiography findings in patients without coronary calcification. AJR Am J Roentgenol 2008;191:50-5. (Pubitemid 351955182)
20. Sosnowski M, Pysz P, Szymanski L, et al. Negative calcium score and the presence of obstructive coronary lesions in patients with intermediate CAD probability. International journal of cardiology 2011;148(1):e16-8.
21. Scholte AJ, Schuijf JD, Kharagjitsingh AV, et al. Prevalence of coronary artery disease and plaque morphology assessed by multi-slice computed tomography coronary angiography and calcium scoring in asymptomatic patients with type 2 diabetes. Heart 2008;94:290-5. (Pubitemid 351303418)
22. Rivera JJ, Nasir K, Choi EK, et al. Detection of occult coronary artery disease in asymptomatic individuals with diabetes mellitus using non-invasive cardiac angiography. Atherosclerosis 2009;203:442-8.
23. Iwasaki K, Matsumoto T, Aono H, et al. Prevalence of subclinical atherosclerosis in asymptomatic diabetic patients by 64-slice computed tomography. Coron Artery Dis 2008;19:195-201. (Pubitemid 351555974)
24. Henneman MM, Schuijf JD, van Werkhoven JM, et al. Multi-slice computed tomography coronary angiography for ruling out suspected coronary artery disease: what is the prevalence of a normal study in a general clinical population? Eur Heart J 2008;29:2006-13.
25. Ostrom MP, Gopal A, Ahmadi N, et al. Mortality incidence and the severity of coronary atherosclerosis assessed by computed tomography angiography. J Am Coll Cardiol 2008;52:1335-43.
26. Bachar GN, Atar E, Fuchs S, et al. Prevalence and clinical predictors of atherosclerotic coronary artery disease in asymptomatic patients undergoing coronary multidetector computed tomography. Coron Artery Dis 2007;18:353-60. (Pubitemid 47186835)
27. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med 1979;300:1350-8. (Pubitemid 9198112)
28. Civeira F. International Panel on Management of Familial H. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis 2004;173:55-68.
29. Neil A, Cooper J, Betteridge J, et al. Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study. Eur Heart J 2008;29:2625-33.
30. Hoffmann U, Moselewski F, Nieman K, et al. Noninvasive assessment of plaque morphology and composition in culprit and stable lesions in acute coronary syndrome and stable lesions in stable angina by multidetector computed tomography. J Am Coll Cardiol 2006;47:1655-62.
31. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc biol 1995;15:1512-31.
32. Achenbach S, Moselewski F, Ropers D, et al. Detection of calcified and noncalcified coronary atherosclerotic plaque by contrast-enhanced, submillimeter multidetector spiral computed tomography: a segment-based comparison with intravascular ultrasound. Circulation 2004;109:14-17. (Pubitemid 38056013)
33. Leber AW, Knez A, Becker A, et al. Accuracy of multidetector spiral computed tomography in identifying and differentiating the composition of coronary atherosclerotic plaques: a comparative study with intracoronary ultrasound. J Am Coll Cardiol 2004;43:1241-7. (Pubitemid 38452602)
34. Meijs MF, Meijboom WB, Prokop M, et al. Is there a role for CT coronary angiography in patients with symptomatic angina? Effect of coronary calcium score on identification of stenosis. Int J Cardiovasc Imaging 2009;25:847-54.
35. Achenbach S, Raggi P. Imaging of coronary atherosclerosis by computed tomography. Eur Heart J 2010;31:1442-8.
36. Perrone-Filardi P, Achenbach S, Mohlenkamp S, et al. Cardiac computed tomography and myocardial perfusion scintigraphy for risk stratification in asymptomatic individuals without known cardiovascular disease: a position statement of the Working Group on Nuclear Cardiology and Cardiac CT of the European Society of Cardiology. Eur Heart J 2010. Published Online First: 14 July 2010. doi:10.1093/eurheartj/ehq235.